{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Version foetale : Questions médicales les plus fréquentes",
"headline": "Version foetale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Version foetale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-08",
"dateModified": "2025-05-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Version foetale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Accouchement (procédure)",
"url": "https://questionsmedicales.fr/mesh/D036861",
"about": {
"@type": "MedicalCondition",
"name": "Accouchement (procédure)",
"code": {
"@type": "MedicalCode",
"code": "D036861",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E04.520.252"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Version foetale",
"alternateName": "Version, Fetal",
"code": {
"@type": "MedicalCode",
"code": "D014710",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "You Jung Han",
"url": "https://questionsmedicales.fr/author/You%20Jung%20Han",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Jin Hoon Chung",
"url": "https://questionsmedicales.fr/author/Jin%20Hoon%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Moon Young Kim",
"url": "https://questionsmedicales.fr/author/Moon%20Young%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Min Hyoung Kim",
"url": "https://questionsmedicales.fr/author/Min%20Hyoung%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, Gangseo Mizmedi Hospital, Seoul, Korea."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery.",
"datePublished": "2023-04-03",
"url": "https://questionsmedicales.fr/article/37019308",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejps.2023.106442"
}
},
{
"@type": "ScholarlyArticle",
"name": "Determination of trypsin using protamine mediated fluorescent enhancement of DNA templated Au nanoclusters.",
"datePublished": "2023-03-27",
"url": "https://questionsmedicales.fr/article/36971858",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00604-023-05754-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Detection of protamine based on competitive adsorption onto the surface of functionalized multi-walled carbon nanotubes.",
"datePublished": "2023-09-16",
"url": "https://questionsmedicales.fr/article/37650445",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/bio.4588"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gradient Nanoconfinement Facilitates Binding of Transcriptional Factor NF-κB to Histone- and Protamine-DNA Complexes.",
"datePublished": "2023-03-01",
"url": "https://questionsmedicales.fr/article/36857512",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.nanolett.3c00325"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet Function is Preserved After Moderate Cardiopulmonary Bypass Times But Transiently Impaired After Protamine.",
"datePublished": "2023-03-13",
"url": "https://questionsmedicales.fr/article/37059638",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1053/j.jvca.2023.03.013"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Procédures de chirurgie opératoire",
"item": "https://questionsmedicales.fr/mesh/D013514"
},
{
"@type": "ListItem",
"position": 3,
"name": "Procédures de chirurgie obstétrique",
"item": "https://questionsmedicales.fr/mesh/D013513"
},
{
"@type": "ListItem",
"position": 4,
"name": "Accouchement (procédure)",
"item": "https://questionsmedicales.fr/mesh/D036861"
},
{
"@type": "ListItem",
"position": 5,
"name": "Version foetale",
"item": "https://questionsmedicales.fr/mesh/D014710"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Version foetale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Version foetale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Version foetale",
"description": "Comment diagnostiquer une présentation en siège ?\nQuels signes indiquent une version fœtale ?\nQuand effectuer une échographie pour la version fœtale ?\nQuels examens préalables à la version fœtale ?\nPeut-on détecter une version fœtale par palpation ?",
"url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Protamines&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Version foetale",
"description": "Quels symptômes peuvent indiquer un siège fœtal ?\nY a-t-il des douleurs associées à la version fœtale ?\nComment se manifeste un fœtus en siège ?\nQuels signes de détresse fœtale peuvent apparaître ?\nLes contractions sont-elles différentes en cas de siège ?",
"url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Protamines&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Version foetale",
"description": "Peut-on prévenir un siège fœtal ?\nLes exercices peuvent-ils aider à la position fœtale ?\nLe yoga peut-il influencer la position fœtale ?\nLes positions de sommeil affectent-elles la version ?\nLes visites régulières chez le médecin sont-elles importantes ?",
"url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Protamines&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Version foetale",
"description": "Comment se déroule une version fœtale ?\nQuels sont les risques de la version fœtale ?\nQuand est-il préférable de ne pas faire de version fœtale ?\nQuels médicaments peuvent être utilisés lors de la version ?\nLa version fœtale est-elle toujours efficace ?",
"url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Protamines&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Version foetale",
"description": "Quelles complications peuvent survenir après une version ?\nLa version fœtale peut-elle entraîner une césarienne ?\nQuels sont les signes d'une complication post-version ?\nLes complications sont-elles fréquentes après une version ?\nComment gérer les complications après une version ?",
"url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Protamines&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Version foetale",
"description": "Quels facteurs augmentent le risque de siège fœtal ?\nL'âge maternel influence-t-il la position fœtale ?\nLes anomalies utérines affectent-elles la version fœtale ?\nLe tabagisme maternel influence-t-il la position fœtale ?\nLes antécédents de césarienne influencent-ils la version ?",
"url": "https://questionsmedicales.fr/mesh/D014710?mesh_terms=Protamines&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une présentation en siège ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie et l'examen pelvien permettent de confirmer la présentation en siège."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une version fœtale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une palpation abdominale révèle la position du fœtus et des mouvements anormaux."
}
},
{
"@type": "Question",
"name": "Quand effectuer une échographie pour la version fœtale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une échographie est recommandée vers la 36e semaine de grossesse pour évaluer la position."
}
},
{
"@type": "Question",
"name": "Quels examens préalables à la version fœtale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen clinique et une échographie sont nécessaires pour évaluer les risques."
}
},
{
"@type": "Question",
"name": "Peut-on détecter une version fœtale par palpation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la palpation abdominale permet d'évaluer la position du fœtus."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un siège fœtal ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une sensation de pression dans le bas-ventre et des mouvements fœtaux anormaux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des douleurs associées à la version fœtale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales peuvent survenir lors de la manœuvre de version."
}
},
{
"@type": "Question",
"name": "Comment se manifeste un fœtus en siège ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le fœtus en siège peut provoquer des douleurs lombaires et une pression pelvienne."
}
},
{
"@type": "Question",
"name": "Quels signes de détresse fœtale peuvent apparaître ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diminution des mouvements fœtaux ou des anomalies du rythme cardiaque."
}
},
{
"@type": "Question",
"name": "Les contractions sont-elles différentes en cas de siège ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les contractions peuvent être plus intenses et moins régulières avec un fœtus en siège."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir un siège fœtal ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie pour prévenir un siège fœtal, mais un suivi régulier aide."
}
},
{
"@type": "Question",
"name": "Les exercices peuvent-ils aider à la position fœtale ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains exercices de positionnement peuvent encourager le fœtus à se retourner."
}
},
{
"@type": "Question",
"name": "Le yoga peut-il influencer la position fœtale ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le yoga prénatal peut aider à améliorer la flexibilité et favoriser une meilleure position."
}
},
{
"@type": "Question",
"name": "Les positions de sommeil affectent-elles la version ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dormir sur le côté gauche peut favoriser une meilleure circulation et position fœtale."
}
},
{
"@type": "Question",
"name": "Les visites régulières chez le médecin sont-elles importantes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles permettent de surveiller la position fœtale et d'anticiper les complications."
}
},
{
"@type": "Question",
"name": "Comment se déroule une version fœtale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La version fœtale est réalisée par un obstétricien, souvent sous échographie et anesthésie."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de la version fœtale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent la rupture des membranes, la détresse fœtale et des saignements."
}
},
{
"@type": "Question",
"name": "Quand est-il préférable de ne pas faire de version fœtale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas de placenta praevia, de malformations fœtales ou de complications maternelles."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent être utilisés lors de la version ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tocolytiques peuvent être administrés pour détendre l'utérus pendant la manœuvre."
}
},
{
"@type": "Question",
"name": "La version fœtale est-elle toujours efficace ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La version fœtale réussit dans environ 50-70% des cas, selon la situation clinique."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une version ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements, des contractions prématurées ou une détresse fœtale peuvent survenir."
}
},
{
"@type": "Question",
"name": "La version fœtale peut-elle entraîner une césarienne ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, si la version échoue ou si des complications surviennent, une césarienne peut être nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une complication post-version ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales intenses, des saignements ou une diminution des mouvements fœtaux."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes après une version ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont rares, mais un suivi médical est essentiel après la procédure."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications après une version ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical étroit et des interventions appropriées sont nécessaires pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de siège fœtal ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les grossesses multiples, l'anatomie pelvienne et les antécédents de siège augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge maternel influence-t-il la position fœtale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes plus âgées peuvent avoir un risque accru de présentation en siège."
}
},
{
"@type": "Question",
"name": "Les anomalies utérines affectent-elles la version fœtale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anomalies utérines peuvent limiter la capacité du fœtus à se positionner correctement."
}
},
{
"@type": "Question",
"name": "Le tabagisme maternel influence-t-il la position fœtale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut affecter le développement fœtal et augmenter le risque de siège."
}
},
{
"@type": "Question",
"name": "Les antécédents de césarienne influencent-ils la version ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents de césarienne peuvent compliquer la version fœtale et augmenter les risques."
}
}
]
}
]
}
The use of oral antibiotic therapy for the treatment of respiratory diseases as tuberculosis has promoted the appearance of side effects as well as resistance to these treatments. The low solubility, ...
A fluorescent method is described for trypsin determination through the strong electrostatic interactions between cationic polyelectrolytes and single-stranded DNA (ssDNA) templated Au nanoclusters (A...
This study developed an adsorption-based determination system for protamine. A multi-walled carbon nanotube (MWCNT), which is a strong adsorbent, was used. The competitive adsorption process between d...
Mechanically induced chromosome reorganization plays important roles in transcriptional regulation. However, the interplay between chromosome reorganization and transcription activities is complicated...
Previous studies have described impaired platelet function after cardiopulmonary bypass (CPB). Whether this is still valid in contemporary cardiac surgery is unclear. This study aimed to quantify chan...
Prospective, controlled clinical study....
A single-center university hospital....
Thirty-nine patients scheduled for coronary artery bypass graft surgery with CPB....
Platelet function and numbers were measured at 6 timepoints in 39 patients during and after coronary artery bypass graft surgery; at baseline before anesthesia, at the end of CPB, after protamine admi...
Platelet function was assessed with impedance aggregometry and flow cytometry. Platelet numbers are expressed as actual concentration and as numbers corrected for dilution using hemoglobin as a refere...
During cardiac surgery with moderate CPB times, platelet function was not impaired, and no consumption of circulating platelets could be detected. Administration of protamine transiently affected plat...
Heparin, an anionic biomacromolecule, is routinely used as an anticoagulant during medical surgery to prevent blood clot formation and in the treatment of several heart, lung, and circulatory disorder...
Our study aim was to explore how different protamine-heparin ratios impacted enzymatic coagulation and acellular fibrin clot growth in plasma using an in vitro model. We hypothesized that a low protam...
We performed an in vitro study using 15 plasma samples from a commercial supplier. Different protamine-heparin ratios were added to each donor plasma sample: low ratio (0.7-1), traditional ratio (1-1)...
Plasma samples treated with a one-to-one protamine-heparin ratio had significantly lower mean initial clot growth velocity compared to samples treated with a low protamine-heparin ratio; mean differen...
Plasma samples treated with a low protamine-heparin ratio had superior clot growth velocity and larger clot size at 30 min compared to a one-to-one ratio, supporting the notion that a low protamine-he...
Excess protamine contributes to coagulopathy following cardiopulmonary bypass (CPB) and may increase blood loss and transfusion requirements. The primary aim of this study was to find the least amount...
Twenty-eight consecutive patients undergoing elective cardiac surgery were enrolled. Protamine administration was standardized through an infusion pump at 25 mg·min...
Following a mean (standard deviation) cumulative heparin dose of 67,700 (19,400) units and a CPB duration of 113 (71) min, protamine requirements varied widely. Eight out of 25 (32%) patients showed c...
The protamine:heparin ratio required to neutralize residual unfractionated heparin (UFH) following CPB is variable. A protamine:heparin ratio of 0.3 was sufficient to neutralize UFH in some patients, ...
ClinicalTrials.gov (NCT03787641); registered 26 December 2018....
Despite major advances, transcatheter aortic valve replacement (TAVR) is still associated with procedure-specific complications. Although previous studies reported lower bleeding rates in patients rec...
The aim of this study was a comparison of two different heparin antagonization regimens for the prevention of bleeding complications after TAVR....
The study included 1446 patients undergoing TAVR, of whom 623 received partial and 823 full heparin antagonization. The primary endpoint was a composite of 30-day mortality, life-threatening, and majo...
Full antagonization of heparin resulted in lower rates of the primary endpoint as compared to partial heparin reversal (5.6% vs. 10.4%, p < .01), which was mainly driven by lower rates of life-threate...
Full heparin antagonization resulted in significantly lower rates of life-threatening and major bleeding after TAVR as compared to partial heparin reversal. The occurrence of stroke and myocardial inf...
In this contribution, we designed and synthesized a deep-red emitting distyryl-BODIPY dye (dye 3) which is non-fluorescent in aqueous solution due to the formation of non-emissive aggregates. However,...